Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 7.018 Q1 | 370 | 185 | 748 | 7859 | 6887 | 412 | 9.31 | 42.48 | |
2 | Trends in Pharmacological Sciences | journal | 4.195 Q1 | 234 | 100 | 285 | 6905 | 2975 | 261 | 10.84 | 69.05 | |
3 | Journal for ImmunoTherapy of Cancer | journal | 4.194 Q1 | 100 | 336 | 336 | 13307 | 3078 | 310 | 9.47 | 39.60 | |
4 | Natural Product Reports | journal | 3.421 Q1 | 200 | 76 | 202 | 11909 | 2230 | 195 | 10.59 | 156.70 | |
5 | Neuropsychopharmacology | journal | 3.122 Q1 | 238 | 300 | 917 | 15641 | 5868 | 848 | 5.69 | 52.14 | |
6 | npj Vaccines | journal | 2.465 Q1 | 39 | 49 | 101 | 2565 | 548 | 99 | 5.60 | 52.35 | |
7 | Journal of Antimicrobial Chemotherapy | journal | 2.230 Q1 | 211 | 593 | 1697 | 17693 | 7880 | 1471 | 4.76 | 29.84 | |
8 | Emerging Microbes and Infections | journal | 2.212 Q1 | 84 | 170 | 406 | 7651 | 2081 | 330 | 4.85 | 45.01 | |
9 | Advanced healthcare materials | journal | 2.135 Q1 | 122 | 337 | 975 | 25720 | 7159 | 950 | 7.57 | 76.32 | |
10 | npj Systems Biology and Applications | journal | 2.043 Q1 | 31 | 37 | 96 | 1754 | 464 | 96 | 4.44 | 47.41 | |
11 | Environmental Pollution | journal | 1.968 Q1 | 275 | 1619 | 3525 | 97760 | 25863 | 3494 | 7.22 | 60.38 | |
12 | Particle and Fibre Toxicology | journal | 1.922 Q1 | 113 | 46 | 166 | 2848 | 1261 | 162 | 7.64 | 61.91 | |
13 | Drug Discovery Today | journal | 1.896 Q1 | 195 | 260 | 615 | 18693 | 4524 | 579 | 7.39 | 71.90 | |
14 | Current Opinion in Systems Biology | journal | 1.809 Q1 | 30 | 76 | 193 | 4997 | 522 | 171 | 2.70 | 65.75 | |
15 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.766 Q1 | 94 | 9 | 63 | 1600 | 426 | 58 | 5.55 | 177.78 | |
16 | Expert Review of Vaccines | journal | 1.746 Q1 | 97 | 102 | 353 | 9704 | 1427 | 312 | 4.33 | 95.14 | |
17 | Expert Opinion on Therapeutic Targets | journal | 1.699 Q1 | 101 | 91 | 319 | 9499 | 1502 | 280 | 4.71 | 104.38 | |
18 | International Journal of Neuropsychopharmacology | journal | 1.695 Q1 | 119 | 59 | 367 | 3337 | 1632 | 355 | 4.10 | 56.56 | |
19 | Neuropharmacology | journal | 1.638 Q1 | 184 | 383 | 1384 | 28749 | 6282 | 1362 | 4.54 | 75.06 | |
20 | Human Genomics | journal | 1.594 Q1 | 64 | 68 | 121 | 1564 | 410 | 117 | 3.24 | 23.00 | |
21 | Addictive Behaviors | journal | 1.558 Q1 | 142 | 444 | 992 | 19733 | 3593 | 970 | 3.75 | 44.44 | |
22 | Clinical Trials | journal | 1.549 Q1 | 71 | 92 | 259 | 2131 | 604 | 212 | 2.05 | 23.16 | |
23 | PharmacoEconomics | journal | 1.453 Q1 | 112 | 123 | 348 | 5332 | 1132 | 303 | 2.98 | 43.35 | |
24 | Clinical Pharmacokinetics | journal | 1.417 Q1 | 176 | 121 | 351 | 6954 | 1565 | 332 | 4.28 | 57.47 | |
25 | British Journal of Clinical Pharmacology | journal | 1.378 Q1 | 161 | 320 | 910 | 12029 | 3331 | 776 | 3.44 | 37.59 | |
26 | F1000Research | journal | 1.357 Q1 | 88 | 800 | 2400 | 37830 | 6953 | 2286 | 2.53 | 47.29 | |
27 | Journal of Psychopharmacology | journal | 1.342 Q1 | 129 | 148 | 436 | 9243 | 1595 | 408 | 3.26 | 62.45 | |
28 | Nanotoxicology | journal | 1.340 Q1 | 101 | 84 | 322 | 5613 | 1856 | 318 | 5.19 | 66.82 | |
29 | Journal of Nanobiotechnology | journal | 1.335 Q1 | 96 | 124 | 271 | 6672 | 1905 | 268 | 7.20 | 53.81 | |
30 | BioDrugs | journal | 1.304 Q1 | 76 | 61 | 153 | 3368 | 741 | 148 | 5.20 | 55.21 | |
31 | EPMA Journal | journal | 1.263 Q1 | 45 | 36 | 95 | 2328 | 675 | 92 | 7.08 | 64.67 | |
32 | CNS Neuroscience and Therapeutics | journal | 1.241 Q1 | 83 | 140 | 364 | 7729 | 1277 | 304 | 3.57 | 55.21 | |
33 | Therapeutic Advances in Neurological Disorders | journal | 1.240 Q1 | 62 | 74 | 161 | 4511 | 721 | 149 | 5.11 | 60.96 | |
34 | Pharmaceutical Statistics | journal | 1.223 Q1 | 42 | 56 | 158 | 1581 | 225 | 154 | 1.30 | 28.23 | |
35 | Acta Pharmacologica Sinica | journal | 1.195 Q1 | 108 | 164 | 497 | 7653 | 2190 | 490 | 4.59 | 46.66 | |
36 | Expert Opinion on Investigational Drugs | journal | 1.180 Q1 | 114 | 105 | 357 | 8288 | 1450 | 338 | 4.61 | 78.93 | |
37 | Clinical and Translational Science | journal | 1.175 Q1 | 56 | 83 | 182 | 2393 | 561 | 154 | 3.10 | 28.83 | |
38 | Toxicological Sciences | journal | 1.175 Q1 | 200 | 285 | 799 | 15152 | 2965 | 738 | 3.59 | 53.16 | |
39 | Drug Discovery Today: Technologies | journal | 1.162 Q1 | 58 | 28 | 103 | 1674 | 402 | 92 | 3.69 | 59.79 | |
40 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 77 | 112 | 313 | 10359 | 1370 | 271 | 4.46 | 92.49 | |
41 | Drug Safety | journal | 1.148 Q1 | 136 | 125 | 352 | 6758 | 1168 | 293 | 3.00 | 54.06 | |
42 | Critical Reviews in Toxicology | journal | 1.107 Q1 | 122 | 38 | 128 | 6684 | 536 | 124 | 4.01 | 175.89 | |
43 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.077 Q1 | 101 | 83 | 224 | 3648 | 826 | 222 | 3.63 | 43.95 | |
44 | Drug Delivery | journal | 1.072 Q1 | 85 | 124 | 748 | 5665 | 3742 | 748 | 5.12 | 45.69 | |
45 | Expert Opinion on Therapeutic Patents | journal | 1.027 Q1 | 83 | 73 | 290 | 6360 | 1374 | 281 | 5.38 | 87.12 | |
46 | Expert Opinion on Drug Delivery | journal | 1.001 Q1 | 126 | 106 | 361 | 11229 | 1811 | 334 | 4.87 | 105.93 | |
47 | Pharmacogenomics Journal | journal | 0.981 Q1 | 93 | 59 | 249 | 3147 | 754 | 244 | 2.90 | 53.34 | |
48 | Pharmacology Research and Perspectives | journal | 0.953 Q1 | 38 | 94 | 228 | 3628 | 570 | 225 | 2.15 | 38.60 | |
49 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.930 Q1 | 95 | 88 | 373 | 8459 | 1271 | 343 | 3.58 | 96.13 | |
50 | Molecular Diagnosis and Therapy | journal | 0.921 Q2 | 50 | 65 | 184 | 5326 | 554 | 180 | 3.18 | 81.94 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®